Denosumab and Osteoporotic Vertebral Compression Fracture

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study aimed to investigate the effect of denosumab on bone mineral density(BMD), bone turnover markers(BTMs), functional status, secondary fracture rate, and adverse effects in osteoporotic vertebral compression fracture (OVCF) patients after vertebroplasty during a 12-month follow-up period.
Epistemonikos ID: eb745c4a9f71ccdcac029244108b5d9621d5fc37
First added on: May 09, 2024